Primary amino-bisphosphonates: A new class of gastrotoxic drugs - Comparison of alendronate and aspirin

American Journal of Gastroenterology

Volumn 92, Issue 8, 1997, Pages 1322-1325

  Graham, David Y ^a   Malaty, H M ^a   Goodgame, Richard ^a  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BISPHOSPHONIC ACID DERIVATIVE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DUODENUM INJURY; ENDOSCOPY; ESOPHAGUS INJURY; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH MUCOSA INJURY;

ADULT; ALENDRONATE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; DOUBLE-BLIND METHOD; ESOPHAGUS; FEMALE; GASTRIC MUCOSA; GASTROSCOPY; HUMANS; MALE; MIDDLE AGED; STOMACH ULCER;

EID: 0030802835     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Fleisch H. The use of bisphosphonates in osteoporosis. Br J Clin Pract 1994;48:323-6.
2. Fleisch H. Bisphosphonates: pharmacology. Semin Arthritis Rheum 1994;23:261-2.